Johnson & Johnson

JNJ

(NYSE)

$ 88,09 <%= Resources.Global.txtUp %>

Opdateret 18-05-2013

Idag

Market closed

Marked er lukket, åbner klokken 15:30

	17 maj	Correction to Thursday's Johnson & Johnson-Metal-on-Metal Hip-Products Story

	17 maj	Johnson & Johnson to Discontinue Metal-on-Metal Hip Products

	13 maj	Johnson & Johnson Unit Gets Priority Revenue for Simeprevir NDA

	09 maj	J&J Settlement with Justice Department On Hold

	03 maj	J&J Recalls Children's Tylenol in South Korea

	01 maj	Johnson & Johnson Myeloma Drug Gets FDA 'Breakthrough' Status

	01 maj	2nd UPDATE: Humana's 1Q Earnings Surge, but 2014 Questions Loom

	01 maj	First Manhattan to Continue With Board Overhaul Push at Vivus

	01 maj	UPDATE: Humana's 1Q Earnings Surge, But 2014 Questions Loom

	29 apr	UPDATE: Health Net Posts First-Quarter Gain Amid Recovery from Rocky 2012

Konsensusmål

86,78 USD

P/E (2013E)

15,9x

K/I (2013E)

3,36x

Direkte afkast (2013E)

2,8%

Konsensus anbefaling

Sælg

Hold

Køb

Åbn analyse

Kilde: FactSet Research

Ingen beskrivelse

For lav Flash Player version